EYPT:NASDAQ
EyePoint Inc
3,23 USD
arrow_downward
-1,22%(-0,040) 1D
3,25 USD
arrow_upward
+0,62% (+0,020)bedtimeAfter hours
Closed: 1-окт., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,29 USD
High
3,45 USD
Low
3,23 USD
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
0,00
52-wk high
19,01 USD
52-wk low
3,23 USD
EPS
-3,74 USD
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Open
3,29 USD
High
3,45 USD
Low
3,23 USD
Mkt. cap
278,47 млн
Avg. vol.
4,15 млн
Volume
0,00
52-wk high
19,01 USD
52-wk low
3,23 USD
EPS
-3,74 USD
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
News stories
From web sources and news partners
openPR.com
·
41 мүнөт мурун
BK Healthcare Appears on Nasdaq MarketSite Screen in Times
Yahoo Finance
·
13 мүнөт мурун
SLS, IBRX Stocks Climb Overnight: Retail Eyes Moderna’s Rally As MRNA Lands A Nasdaq-100 Spot
Seeking Alpha
·
46 мүнөт мурун
1 October 2026: The Nasdaq Is Failing To Overcome Its June Resistance High (NASDAQ:QQQ)
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersУотертаун, Массачусетс, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio